Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Tamibarotene

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tamibarotene

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rege Nephro Completes Series B Funding For Kidney Disease Trials
    Rege Nephro Completes Series B Funding For Kidney Disease Trials

    07 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rege-nephro-co-ltd-successfully-completes-series-b-funding-to-accelerate-kidney-disease-therapy-trials-302268655.html

    PR NEWSWIRE
    07 Oct 2024
    Share Share
    Syros To Host Webcast On MDS, Tamibarotene Opportunity In RARA Overexpression
    Syros To Host Webcast On MDS, Tamibarotene Opportunity In RARA Overexpression

    13 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240613264695/en

    BUSINESSWIRE
    13 Jun 2024
    Share Share
    Rege Nephro: Phase 2 Tamibarotene Trial In ADPKD Patient Enrollment
    Rege Nephro: Phase 2 Tamibarotene Trial In ADPKD Patient Enrollment

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rege-nephro-co-ltd-announces-patient-enrollment-for-phase-ii-clinical-trial-of-tamibarotene-for-adpkd-302155910.html

    PR NEWSWIRE
    28 May 2024
    Share Share
    Syros Highlights 2024 Milestones to Deliver on the Value of Tamibarotene
    Syros Highlights 2024 Milestones to Deliver on the Value of Tamibarotene

    08 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240108581653/en

    BUSINESSWIRE
    08 Jan 2024
    Share Share
    Syros’ stock up after sharing early, mid-stage AML data
    Syros’ stock up after sharing early, mid-stage AML data

    07 Dec 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://ftp.tmfsummit.com/biotech/syros-stock-after-sharing-early-mid-stage-aml-data

    Gabrielle Masson FIERCE BIOTECH
    07 Dec 2023
    Share Share
    Syros Announces Initial Data from Phase 2 Trial Evaluating Tamibarotene
    Syros Announces Initial Data from Phase 2 Trial Evaluating Tamibarotene

    06 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231206147296/en

    BUSINESSWIRE
    06 Dec 2023
    Share Share